AR is trading at $4.93, up 3.98% over 24 hours and 6.27% over seven days. The daily range was $4.61–$5.13, placing the current price in the upper portion of the range, though still $0.20 below the high.

The short-term price action is positive, but the weekly gain is modest compared with the larger two- and four-week advances. This suggests that AR remains higher over those broader periods, while the latest week has seen slower progress.

All five listed hourly moving averages are below the current price, from the 8-hour SMA at $4.91 down to the 144-hour SMA at $4.56. Their orderly progression, with longer-period averages lower than shorter-period averages, supports a bullish trend reading rather than a reversal signal.

The 1-hour RSI of 62 is consistent with positive near-term momentum, while the 7-day RSI of 52 is closer to neutral. These readings are not fully aligned: the hourly measure is stronger, but the weekly measure does not confirm equally strong momentum across the broader timeframe.

Returns are sharply positive over 14 days (+73.49%) and 30 days (+140.40%), compared with +6.27% over seven days. The substantial difference indicates that much of the measured advance occurred before the latest week, making the recent pace a reason for caution despite the still-positive trend.

The price remains above every supplied moving average, and the 24-hour change is positive, both supporting continued strength. However, the price has not reached the daily high, and the weekly RSI is near the midpoint, so the supplied data do not show equally strong confirmation across all timeframes.

Reported 24-hour volume is 24.13 million, with volume equal to 7.45% of market capitalization. This establishes meaningful traded activity in the supplied snapshot, but without historical volume figures it is not possible to determine whether participation is rising or unusually high.

AR is about 94.5% below its all-time high of $89.24, recorded in November 2021. That distance provides historical price context, but the supplied data do not establish that the old high is a relevant near-term target or that price is likely to return to it.

The overall rating is Hold. The moving-average alignment, positive daily move, and large 14- and 30-day gains are bullish, but the much smaller seven-day advance and near-neutral weekly RSI temper the case for a Buy; the available evidence also does not show a clear bearish breakdown to support a Sell.

The primary evidence for Hold is the tension between a price above all listed moving averages and strong broader-period returns, versus slower recent weekly performance and only neutral-to-moderate weekly RSI. This supports a positive trend assessment, but not an unequivocal signal of strengthening momentum.